AR056125A1 - Procedimiento para el diagnostico de tromboembolias y cardiopatias isquemicas - Google Patents

Procedimiento para el diagnostico de tromboembolias y cardiopatias isquemicas

Info

Publication number
AR056125A1
AR056125A1 ARP060104446A ARP060104446A AR056125A1 AR 056125 A1 AR056125 A1 AR 056125A1 AR P060104446 A ARP060104446 A AR P060104446A AR P060104446 A ARP060104446 A AR P060104446A AR 056125 A1 AR056125 A1 AR 056125A1
Authority
AR
Argentina
Prior art keywords
diagnosis
thromboembolies
cardiopatias
ischemical
procedure
Prior art date
Application number
ARP060104446A
Other languages
English (en)
Spanish (es)
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of AR056125A1 publication Critical patent/AR056125A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP060104446A 2005-10-12 2006-10-10 Procedimiento para el diagnostico de tromboembolias y cardiopatias isquemicas AR056125A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005048899A DE102005048899A1 (de) 2005-10-12 2005-10-12 Verfahren zur Diagnose thromboembolischer Erkrankungen und koronarer Herzerkrankungen

Publications (1)

Publication Number Publication Date
AR056125A1 true AR056125A1 (es) 2007-09-19

Family

ID=37684083

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104446A AR056125A1 (es) 2005-10-12 2006-10-10 Procedimiento para el diagnostico de tromboembolias y cardiopatias isquemicas

Country Status (14)

Country Link
US (1) US20090197774A1 (https=)
EP (1) EP1937839B1 (https=)
JP (1) JP2009511026A (https=)
KR (1) KR20080052662A (https=)
CN (1) CN101287846A (https=)
AR (1) AR056125A1 (https=)
AT (1) ATE525481T1 (https=)
AU (1) AU2006301578B9 (https=)
BR (1) BRPI0617341A2 (https=)
CA (1) CA2625698A1 (https=)
DE (1) DE102005048899A1 (https=)
IL (1) IL190585A (https=)
TW (1) TW200734638A (https=)
WO (1) WO2007042165A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005048898A1 (de) * 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen
US20100197518A1 (en) 2007-05-01 2010-08-05 Huichun Xu Methods for Diagnosing Ischemia
EP2593566B1 (en) 2010-07-14 2018-01-24 The Regents of The University of California Biomarkers for diagnosis of transient ischemic attacks
US20120065087A1 (en) 2010-07-15 2012-03-15 Regents Of The University Of California Biomarkers for diagnosis of stroke and its causes
US20120316076A1 (en) 2011-03-04 2012-12-13 The Regents Of The University Of California Biomarkers for the diagnosis of lacunar stroke
CN104094121B (zh) * 2011-12-01 2016-10-26 霍夫曼-拉罗奇有限公司 用于诊断中风的nt-原anp和nt-原bnp
US9410204B2 (en) 2012-01-07 2016-08-09 The Regents Of The University Of California Biomarkers for diagnosing ischemia
KR101939778B1 (ko) 2012-07-27 2019-01-18 삼성전자주식회사 필요 혈류량 결정 방법 및 장치, 혈류 영상 생성 방법 및 장치, 심근 관류 영상 처리 방법 및 장치
CN119846215B (zh) * 2025-01-22 2025-07-11 广西医科大学附属肿瘤医院 Egln1乳酸化作为靶点在制备肿瘤诊断试剂盒或治疗药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1583770A4 (en) * 2002-12-20 2006-10-18 Applera Corp STENOSIS-ASSOCIATED GENETIC POLYMORPHIA, DETECTION METHOD AND ITS USE
CA2941594C (en) * 2002-12-20 2021-07-06 Celera Corporation Genetic polymorphisms of the protein receptor c (procr) associated with myocardial infarction, methods of detection and uses thereof

Also Published As

Publication number Publication date
AU2006301578B2 (en) 2011-12-01
TW200734638A (en) 2007-09-16
DE102005048899A1 (de) 2007-04-19
IL190585A (en) 2011-12-29
BRPI0617341A2 (pt) 2011-07-26
AU2006301578A1 (en) 2007-04-19
IL190585A0 (en) 2008-11-03
US20090197774A1 (en) 2009-08-06
KR20080052662A (ko) 2008-06-11
ATE525481T1 (de) 2011-10-15
JP2009511026A (ja) 2009-03-19
CA2625698A1 (en) 2007-04-19
AU2006301578B9 (en) 2011-12-22
EP1937839A1 (de) 2008-07-02
EP1937839B1 (de) 2011-09-21
WO2007042165A1 (de) 2007-04-19
CN101287846A (zh) 2008-10-15

Similar Documents

Publication Publication Date Title
EP2423233A4 (en) BY IN VIVO RELEASE STABILIZED FUSION PROTEIN WITH INCREASED IN VIVO HALF TIME, AND PROCEDURE TO INCREASE IN VIVO HALF TIME
WO2008055078A3 (en) Identification of emotional states using physiological responses
EP2517727A3 (en) Biomarkers for multiple sclerosis and methods of use thereof
DE602005023608D1 (de) Vorrichtung, system und verfahren zur in-vivo-probenentnahme
DE602005026789D1 (de) Le
BRPI0617479A2 (pt) método e composição útil para manter ou melhorar a saúde gastrintestiinal de um animal, kit, meio para comunicação de informações ou instruções, e, uso de uma composição
EP2498095A3 (en) Use of IGFBP-7 in the assessment of heart failure
WO2008021515A3 (en) Methods of determining levels of free amino acids and dipeptides and diagnosing alzheimer's diseases
CY1115212T1 (el) Διαμεσολαβηση στην κυτταροτοξικοτητα των κυτταρων που παρουσιαζουν eπιφaneiakh εκφραση της cd44
AR056125A1 (es) Procedimiento para el diagnostico de tromboembolias y cardiopatias isquemicas
MXPA05006382A (es) Uso de nicotinamida n-metiltransferasa como un marcador para cancer colorrectal.
WO2007000320A3 (de) Verfahren zur diagnose von rheumatischen erkrankungen
WO2008016385A3 (en) Deacylase polypeptides, deacylase polynucleotides, and methods of use thereof
TW200637875A (en) Cytotoxicity mediation of cells evidencing surface expression of CD63
DE602006012995D1 (de) Brustkrebsdiagnoseverfahren
EP1862433A4 (en) PERSONALIZED SYNTHETIC DIAMOND WITH DIFFERENT COLORS, OBTAINED FROM KERATIN (LIVING OR DEAD) HUMANS OR ANIMALS AND MANUFACTURING PROCESS THEREFOR
WO2007010110A3 (fr) Procede de detection des fpca utilisant un agent d'agregation des fpca et un agent de capture des agregats formes
WO2006022619A3 (en) Methods for identifying risk of type ii diabetes and treatments thereof
AR056831A1 (es) Metodo para el diagnostico y tratamiento de enfermedades cardiovasculares
ATE531791T1 (de) Verfahren zur gewinnung menschlicher glatter muskelzellen und verwendungen davon
DE60336596D1 (de) Ortspezifische verabreichung von aktiven substanzen im darm
IL211178A0 (en) Association of protein polymorphisms with coronary heart disease
ATE483973T1 (de) Cross-spot
WO2005040409A3 (de) Verfahren zur diagnose rheumatoider erkrankungen und mittel hierfür
KR100514432B1 (ko) 유전자변형 식물체 분석용 프라이머 세트, 프로브 및표준플라스미드

Legal Events

Date Code Title Description
FB Suspension of granting procedure